3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
5
Uterine Cervical Neoplasms
2
Rectal Neoplasms
2
Neoplasms
2
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Prostatic Neoplasms
1
Prostate Cancer, Hereditary, 7
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
Oropharyngeal Neoplasms
1
Muscle Weakness
1
Lung Neoplasms
1
Liver Neoplasms
1
Kidney Neoplasms
1
Hypoxia
1
Glioma
1
Glioblastoma
1
Gastrointestinal Neoplasms
1
Disease
1
Colonic Neoplasms
1
Astrocytoma
1
Anus Neoplasms
1
Interventions
fludarabine phosphate
2
fludarabine
2
blinatumomab
2
Radiotherapy
2
Cyclophosphamide
2
trastuzumab deruxtecan
1
tislelizumab
1
tisagenlecleucel
1
talquetamab
1
obinutuzumab
1
Trastuzumab
1
Monatide (IMS 3015)
1
Maintenance
1
HMPL-013
1
Cetuximab
1
Blood Specimen Collection
1
Biological Assay
1
Ado-Trastuzumab Emtansine
1
AP 1903 reagent
1
ALT-803
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neoplasm, Residual
×
Magnetic Resonance Imaging
×
30 days
×
Clear all
No trials found.